E-LIB Suche - Ergebnisse für: Fukasawa, Satoshi

1

Pembrolizumab plus enzalutamide for metastatic castration-r..:

Graff, Julie N. ; Hoimes, Christopher J. ; Gerritsen, Winald R....
Prostate Cancer and Prostatic Diseases. , 2024

2

TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Che..:

Nishiyama, Hiroyuki ; Yonese, Junji ; Kawahara, Takashi...
Molecular Cancer Therapeutics. 23 (2023) 4 - p. 532-540 , 2023

Link: https://doi.org/10.1158/..

3

Real‐world effectiveness of nivolumab and subsequent therap..:

Yonese, Junji ; Hinata, Nobuyuki ; Masui, Satoru...
International Journal of Urology. 30 (2023) 9 - p. 762-771 , 2023

Link: https://doi.org/10.1111/..

4

Development and validation of novel nomogram to identify th..:

Goto, Yusuke ; Utsumi, Takanobu ; Maruo, Masafumi...
International Journal of Urology. 30 (2023) 8 - p. 659-665 , 2023

Link: https://doi.org/10.1111/..

5

Lenvatinib plus pembrolizumab versus sunitinib for advanced..:

Eto, Masatoshi ; Takagi, Toshio ; Kimura, Go...
Cancer Medicine. 12 (2022) 6 - p. 6902-6912 , 2022

Link: https://doi.org/10.1002/..

6

Efficacy and safety of subsequent molecular targeted therap..:

Tomita, Yoshihiko ; Kimura, Go ; Fukasawa, Satoshi...
Japanese Journal of Clinical Oncology. 51 (2021) 6 - p. 966-975 , 2021

Link: https://doi.org/10.1093/..

7

Enzalutamide with androgen deprivation therapy in Japanese ..:

Iguchi, Taro ; Kimura, Go ; Fukasawa, Satoshi...
International Journal of Urology. 28 (2021) 7 - p. 765-773 , 2021

Link: https://doi.org/10.1111/..

8

Subgroup analysis of the AFTER I-O study: a retrospective s..:

Tomita, Yoshihiko ; Kimura, Go ; Fukasawa, Satoshi...
Japanese Journal of Clinical Oncology. 51 (2021) 11 - p. 1656-1664 , 2021

Link: https://doi.org/10.1093/..

9

Erratum to: Subgroup analysis of the AFTER I-O study: a ret..:

Tomita, Yoshihiko ; Kimura, Go ; Fukasawa, Satoshi...
Japanese Journal of Clinical Oncology. 51 (2021) 12 - p. 1770-1770 , 2021

Link: https://doi.org/10.1093/..

10

Efficacy and safety of abiraterone acetate plus prednisone ..:

Matsubara, Nobuaki ; Fizazi, Karim ; Mundle, Suneel...
Japanese Journal of Clinical Oncology. 50 (2020) 7 - p. 810-820 , 2020

Link: https://doi.org/10.1093/..

11

Prognostic factors influencing overall survival in de novo ..:

Rii, Junryo ; Sakamoto, Shinichi ; Yamada, Yasutaka...
The Prostate. 80 (2020) 11 - p. 850-858 , 2020

Link: https://doi.org/10.1002/..

12

Efficacy and safety of darolutamide in Japanese patients wi..:

Uemura, Hiroji ; Matsushima, Hisashi ; Kobayashi, Kazuki...
International Journal of Clinical Oncology. 26 (2020) 3 - p. 578-590 , 2020

Link: https://doi.org/10.1007/..

13

Nivolumab versus everolimus in patients with advanced renal..:

Motzer, Robert J. ; Escudier, Bernard ; George, Saby...
Cancer. 126 (2020) 18 - p. 4156-4167 , 2020

Link: https://doi.org/10.1002/..

14

A multicenter retrospective study of nivolumab monotherapy ..:

Hinata, Nobuyuki ; Yonese, Junji ; Masui, Satoru...
International Journal of Clinical Oncology. 25 (2020) 8 - p. 1533-1542 , 2020

Link: https://doi.org/10.1007/..

15

Prognostic factors and survival in Japanese patients with b..:

Takeshita, Nobushige ; Otsuka, Masafumi ; Kamasako, Tomohiko...
International Journal of Clinical Oncology. 24 (2019) 10 - p. 1231-1237 , 2019

Link: https://doi.org/10.1007/..